Bio-Techne · 5 hours ago
Software Developer Intern
Wallingford, CT
Internship
Hybrid
Intern
$17.60/hr - $24.20/hrBio-Techne is a company enabling cutting-edge research in Life Sciences and Clinical Diagnostics. They are seeking a Software Developer Intern to apply software engineering skills in the development of analytical applications and enterprise business applications while collaborating with other engineers and scientists.
BiotechnologyGeneticsManufacturingMedicalMedical Device
No H1B
Responsibilities
Participate in all phases of the software development lifecycle: planning, design, coding, testing, and deployment using Agile methodologies
Design and implement efficient, reliable, testable, and maintainable code
Collaborate cross-functionally within organization to deliver high-impact solutions
Qualification
Required
Must currently be a student enrolled at an accredited institution pursuing a Bachelor's degree in Computer Science or related technical field (e.g., Physics, Mathematics, Biomedical Engineering)
Must at a minimum have completed sophomore year of college
Must be able to work full-time during the duration of the internship program
Familiarity with C#, Java, Javascript, HTML, and CSS
Good understanding of database management systems
Familiarity with software development concepts
Ability to work both independently and collaboratively
Benefits
Medical, dental, vision, life, short-term disability, long-term disability, pet, and legal and ID shield
401k plans
Employee stock purchase plan (ESPP)
Health Saving Account (HSA)
Flexible Spending Account (FSA)
Dependent Care FSA
Mentorship
Promotional opportunities
Training and development
Tuition reimbursement
Internship programs
Employee resource groups
Volunteer paid time off
Employee events
Charity drives
Accrued leave policy
Paid holidays
Paid time off
Paid parental leave
Company
Bio-Techne
Bio-Techne is a supplier of tools for life science research, therapeutic manufacturing, and clinical diagnostics.
Founded in 1981
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
unknown1989-05-19IPO
Leadership Team
Kim Kelderman
President and Chief Executive Officer
Gary Latham
Chief Technology Officer
Recent News
2025-12-24
2025-12-13
Company data provided by crunchbase